Welcome to Pharmacovigilance 2.0

Advera Health's proprietary clinical trials safety outcomes database, when linked with optimized post-approval spontaneous reporting data from the FDA Adverse Event Reporting System (FAERS) and VigiBase, claims data, and social media monitoring provides pharmacovigilance professionals with the software, data, and analytics to track emerging safety issues through multiple data sets, validate signals seen in spontaneous reporting, and engage across these various data sets in a dynamic and proactive manner. 

About Evidex®

Advera Health’s Evidex® is a drug safety data aggregation platform that makes disparate drug safety data actionable though a simple to use yet powerful web-based application, empowering use at all organizational levels. Evidex is the gold standard resource for drug safety knowledge and insight, generated through proprietary curated data and analytics and powerful data integrations, enabling previously unavailable in-depth, rigorous adverse event analysis.

Related Content

What happens when a Safety Signal contradicts Clinical Trial data?

Calculating the Reporting Rate of Adverse Events in FAERS – A New Methodology

Adverse Drug Event Reporting Rates: Comparing FAERS to Clinical Trials

Using FAERS Data and Clinical Evidence to Compare HER2+ Antagonists


Safety Outcomes

First of its kind safety focused clinical trial outcomes database, only available in Evidex. Analyze safety data from 10,000+ trials with a databased version of a literature review. 


Fully Integrated with Evidex

Native integration between Advera Health's Clinical Trial Safety Results Database and Evidex allows for standardized views, but with the flexibility for deeper customization


Powerful Signal Management

Evidex + Clinical Trial Safety Results = integrated signal validation. Save time and provide safety reviewers with the data, analytics, and insight that they need to validate signals. 

New Call-to-action